filings.toolsItem 1A. Risk Factors
2K characters. Original on sec.gov · Markdown
Item 1A. Risk Factors
We face a number of significant risks and uncertainties in connection with our operations. Our business and the results of our operations and financial condition could be materially adversely affected by these risk factors. There have been no material changes to the Risk Factors disclosed in our 2022 Form 10-K.
GENERAL MOTORS COMPANY AND SUBSIDIARIES
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Purchases of Equity Securities The following table summarizes our purchases of common stock in the three months ended March 31, 2023:
| Total Number of Shares Purchased(a)(b) | Weighted Average Price Paid per Share(c) | Total Number of Shares Purchased Under Announced Programs(b) | Approximate Dollar Value of Shares That May Yet be Purchased Under Announced Programs | ||||||||||||||||||||
| January 1, 2023 through January 31, 2023 | 22,216 | $ | 33.97 | — | $2.5 billion | ||||||||||||||||||
| February 1, 2023 through February 28, 2023 | 6,180,726 | $ | 41.24 | 3,985,294 | $2.3 billion | ||||||||||||||||||
| March 1, 2023 through March 31, 2023 | 5,276,241 | $ | 38.06 | 5,276,241 | $2.1 billion | ||||||||||||||||||
| Total | 11,479,183 | $ | 39.76 | 9,261,535 |
(a)Shares purchased consist of shares delivered by employees or directors to us for the payment of taxes resulting from the issuance of common stock upon the vesting of RSUs and PSUs relating to compensation plans. Refer to our 2022 Form 10-K for additional details on employee stock incentive plans.
(b)In January 2017, we announced that our Board of Directors had authorized the purchase of up to $5.0 billion of our common stock with no expiration date. In August 2022, the Board of Directors increased the capacity to $5.0 billion from the $3.3 billion that remained as of June 30, 2022, with no expiration.
(c)The weighted-average price paid per share excludes broker commissions.
GENERAL MOTORS COMPANY AND SUBSIDIARIES
Previous: Item 4. Controls and Procedures · Next: Item 6. Exhibits